2020
DOI: 10.1186/s40352-020-00108-4
|View full text |Cite
|
Sign up to set email alerts
|

“It’s like I was out there by myself”: The receipt of reentry support among HIV-infected formerly incarcerated individuals in New York City

Abstract: Background: In the U.S., approximately one in seven HIV-infected individuals experience incarceration at least once in their lifetime. While HIV-infected individuals experience positive health outcomes during periods of incarceration, they tend to experience treatment disruption as they return to their community after custody which results in poor health outcomes. The purpose of this study was to explore the transitional support received from the Department of Corrections during the reentry period. Methods: We… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 42 publications
0
2
0
Order By: Relevance
“…Individuals with HIV/AIDS who have been previously incarcerated often experience relapsed drug use, which disrupts their medical treatment and makes the potential of re-incarceration for substance use more likely ( Swan, 2015 ). Drawing from interviews with HIV-infected formerly incarcerated individuals in New York, Rowell-Cunsolo et al (2020) , find that study participants vary in how much antiretroviral medication they are provided by their prison upon their release—over a third received an amount that would last them less than a month. Sidibe et al (2015) and Solomon et al (2014) similarly find that HIV-infected individuals experience obstacles to maintaining care and antiretroviral therapy once they are released from prison.…”
Section: Churn and Hiv/aidsmentioning
confidence: 99%
“…Individuals with HIV/AIDS who have been previously incarcerated often experience relapsed drug use, which disrupts their medical treatment and makes the potential of re-incarceration for substance use more likely ( Swan, 2015 ). Drawing from interviews with HIV-infected formerly incarcerated individuals in New York, Rowell-Cunsolo et al (2020) , find that study participants vary in how much antiretroviral medication they are provided by their prison upon their release—over a third received an amount that would last them less than a month. Sidibe et al (2015) and Solomon et al (2014) similarly find that HIV-infected individuals experience obstacles to maintaining care and antiretroviral therapy once they are released from prison.…”
Section: Churn and Hiv/aidsmentioning
confidence: 99%
“…Structural factors such as unstable housing, gaps in health insurance coverage, stigma associated with having HIV, and a history of incarceration may limit the ability of formerly incarcerated individuals to engage in HIV care and maintain optimal ART adherence (Baillargeon et al, 2009;Booker et al, 2013;Dennis et al;DiPrete et al, 2019;Fu et al, 2013;Haley et al;Katzen, 2011;Loeliger et al, 2018;Rich et al, 2013;Stephenson et al, 2005;Westergaard et al, 2013). Accessing providers in a timely manner to prevent treatment disruption during their return to the community has been identified as a primary concern among formerly incarcerated PLWH (Loeliger et al, 2018;Rowell-Cunsolo et al, 2020b;Wohl et al, 2011). Additionally, substance use challenges, which are commonly experienced by formerly incarcerated people who use drugs (Chamberlain et al, 2019;Owens et al, 2018), compound and complicate the ability to overcome many of these structural and community-level barriers (Dennis et al, 2015).…”
Section: Introductionmentioning
confidence: 99%